Careers
ExploreReferences for Prostate Cancer
Author: Dr. Reeja Tharu
Editor: The Medindia Medical Review Team
Technically Checked by: Lingaraj
Editor: The Medindia Medical Review Team
Technically Checked by: Lingaraj
 |
 |
|
 |
|
Font : A-A+ |
Subscribe to our Free Newsletters!
Abarelix is used to treat prostate cancer for reducing the symptoms and to increase the quality of life in patients.Abarelix ...
Abiraterone acetate is used along with prednisolone (corticosteroid) for treating a type of prostate cancer called ...
Apalutamide is a nonsteroidal antiandrogen agent or an androgen receptor inhibitor which is prescribed to treat adult male ...
This medication is a non-steroidal anti-androgen, prescribed for prostate ...
This medication is a gonadotropin-releasing hormone agonist, prescribed for prostate cancer and breast ...
View All
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2020
This site complies with the HONcode standard for trustworthy health information:
verify here.
what are the chances of prostate cancer after the age of 69yrs.
Abiraterone in prostate cancer
The big news in oncology has been Johnson and Johnson purchasing Cougar Biotechnology for $1 billion. They have just bought promising prostate cancer compound, abiraterone.
So look out for this oral drug.
Dr.Shroff
The data hasn't even been announced at ASCO yet, that's this weekend coming, so one can only speculate that suitors got a sneak peek of the data under an NDA. A billion dollars certainly gets attention and raises the ante for future small oncology biotech deals.